Contract 75A50325F80009
Chartwell Rx Llc · Department Of Health And Human Services · August 12, 2025
Chartwell Rx Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 12, 2025 for $57.67 million of work in pharmaceutical preparation manufacturing. Performance is in Congers, NY. This is a task or delivery order issued under parent IDIQ 36F79720D0198. It was awarded under a small business set-aside. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 12, 2025. If all options are exercised, the contract could reach $167.96 million.
Contract details
- PIID
- 75A50325F80009
- Parent IDIQ
- 36F79720D0198
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Congers, NY
- First action
- August 12, 2025
- Latest action
- December 12, 2025
Description
MODIFICATION TO UPDATE THE PERIOD OF PERFORMANCE ON ORDERING PERIOD 2.
Modification timeline
-
December 12, 2025Mod P00002 · Supplemental Agreement For Work Within Scope$98.68M
-
August 12, 2025Mod P00001 · Exercise An OptionEXERCISE OPTIONAL ORDERING PERIOD YEAR 2 DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS$98.68M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50325F80009?
Contract 75A50325F80009 is a federal contract awarded to Chartwell Rx Llc by Department Of Health And Human Services on August 12, 2025 for $57.67 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75A50325F80009?
Chartwell Rx Llc won contract 75A50325F80009 from Department Of Health And Human Services.
How much is contract 75A50325F80009 worth?
Contract 75A50325F80009 has obligated $57.67 million to date, with a total potential value of $167.96 million if all options are exercised.